My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 232

    1.

    Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice.

    Cheung AK, Fung MK, Lo AC, Lam TT, So KF, Chung SS, Chung SK.

    Diabetes. 2005 Nov;54(11):3119-25.PMID: 16249434 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Gene deletion and pharmacological inhibition of aldose reductase protect against retinal ischemic injury.

    Cheung AK, Lo AC, So KF, Chung SS, Chung SK.

    Exp Eye Res. 2007 Nov;85(5):608-16. Epub 2007 Jul 25.PMID: 17727843 [PubMed - indexed for MEDLINE]Related articles

    3.

    Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis.

    Drel VR, Pacher P, Ali TK, Shin J, Julius U, El-Remessy AB, Obrosova IG.

    Int J Mol Med. 2008 Jun;21(6):667-76.PMID: 18506358 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition.

    Vinores SA, Van Niel E, Swerdloff JL, Campochiaro PA.

    Exp Eye Res. 1993 Dec;57(6):723-35.PMID: 8150024 [PubMed - indexed for MEDLINE]Related articles

    5.

    Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.

    Kaji Y, Usui T, Ishida S, Yamashiro K, Moore TC, Moore J, Yamamoto Y, Yamamoto H, Adamis AP.

    Invest Ophthalmol Vis Sci. 2007 Feb;48(2):858-65.PMID: 17251488 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Suppression of Fas-FasL-induced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocin-induced diabetes.

    Joussen AM, Poulaki V, Mitsiades N, Cai WY, Suzuma I, Pak J, Ju ST, Rook SL, Esser P, Mitsiades CS, Kirchhof B, Adamis AP, Aiello LP.

    FASEB J. 2003 Jan;17(1):76-8. Epub 2002 Nov 15.PMID: 12475915 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes.

    Canning P, Glenn JV, Hsu DK, Liu FT, Gardiner TA, Stitt AW.

    Exp Diabetes Res. 2007;2007:51837.PMID: 17641742 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats.

    Obrosova IG, Minchenko AG, Vasupuram R, White L, Abatan OI, Kumagai AK, Frank RN, Stevens MJ.

    Diabetes. 2003 Mar;52(3):864-71.PMID: 12606532 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Systemic administration of HMG-CoA reductase inhibitor protects the blood-retinal barrier and ameliorates retinal inflammation in type 2 diabetes.

    Li J, Wang JJ, Chen D, Mott R, Yu Q, Ma JX, Zhang SX.

    Exp Eye Res. 2009 Jun 15;89(1):71-8. Epub 2009 Feb 28.PMID: 19254713 [PubMed - indexed for MEDLINE]Related articles

    10.

    Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes.

    El-Remessy AB, Al-Shabrawey M, Khalifa Y, Tsai NT, Caldwell RB, Liou GI.

    Am J Pathol. 2006 Jan;168(1):235-44.PMID: 16400026 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Blood-retinal barrier breakdown induced by activation of protein kinase C via vascular endothelial growth factor in streptozotocin-induced diabetic rats.

    Xu X, Zhu Q, Xia X, Zhang S, Gu Q, Luo D.

    Curr Eye Res. 2004 Apr;28(4):251-6.PMID: 15259294 [PubMed - indexed for MEDLINE]Related articles

    12.

    Sorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured retinal pericytes.

    Amano S, Yamagishi S, Kato N, Inagaki Y, Okamoto T, Makino M, Taniko K, Hirooka H, Jomori T, Takeuchi M.

    Biochem Biophys Res Commun. 2002 Nov 29;299(2):183-8.PMID: 12437967 [PubMed - indexed for MEDLINE]Related articles

    13.

    Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.

    Kim JH, Kim JH, Yu YS, Cho CS, Kim KW.

    J Cereb Blood Flow Metab. 2009 Mar;29(3):621-8. Epub 2008 Dec 24.PMID: 19107135 [PubMed - indexed for MEDLINE]Related articles

    14.

    A decrease in retinal progenitor cells is associated with early features of diabetic retinopathy in a model that combines diabetes and hypertension.

    Lopes de Faria JM, Silva KC, Boer PA, Cavalcanti TC, Rosales MA, Ferrari AL, Lopes de Faria JB.

    Mol Vis. 2008 Sep 11;14:1680-91.PMID: 18806882 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    [Aging and retinal vascular diseases]

    Takagi H.

    Nippon Ganka Gakkai Zasshi. 2007 Mar;111(3):207-30; discussion 231. Review. Japanese. PMID: 17402563 [PubMed - indexed for MEDLINE]Related articles

    16.

    Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy.

    Al-Shabrawey M, Bartoli M, El-Remessy AB, Ma G, Matragoon S, Lemtalsi T, Caldwell RW, Caldwell RB.

    Invest Ophthalmol Vis Sci. 2008 Jul;49(7):3231-8. Epub 2008 Mar 31.PMID: 18378570 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vector.

    Shyong MP, Lee FL, Kuo PC, Wu AC, Cheng HC, Chen SL, Tung TH, Tsao YP.

    Mol Vis. 2007 Jan 31;13:133-41.PMID: 17293777 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.

    Skondra D, Noda K, Almulki L, Tayyari F, Frimmel S, Nakazawa T, Kim IK, Zandi S, Thomas KL, Miller JW, Gragoudas ES, Hafezi-Moghadam A.

    Invest Ophthalmol Vis Sci. 2008 Feb;49(2):726-31.PMID: 18235021 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Glial cell-derived cytokines attenuate the breakdown of vascular integrity in diabetic retinopathy.

    Nishikiori N, Osanai M, Chiba H, Kojima T, Mitamura Y, Ohguro H, Sawada N.

    Diabetes. 2007 May;56(5):1333-40.PMID: 17470563 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy.

    Kowluru RA, Atasi L, Ho YS.

    Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1594-9.PMID: 16565397 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity